Home

Hikal Ltd PE Ratio

Image

Hikal Ltd

NSE: HIKAL

PE

61.4

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Hikal Ltd is 61.4 as of 15 Jan 10:32 AM .
  • The P/E Ratio of Hikal Ltd changed from 10.2 on March 2020 to 47 on March 2024 . This represents a CAGR of 35.74% over 5 years.
  • The Latest Trading Price of Hikal Ltd is ₹ 358.65 as of 15 Jan 10:24 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Hikal Ltd

No data available

Company Fundamentals for Hikal Ltd

Image

Hikal Ltd

NSE: HIKAL

Share Price

₹ 358.65

-7.30 (-1.99%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Hikal Ltd

1M

1Y

3Y

5Y

Monitoring Hikal Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 2025365.95
13 Jan 2025347.6
10 Jan 2025358.1
09 Jan 2025371.65
08 Jan 2025381.45
07 Jan 2025391.1
06 Jan 2025379.85
03 Jan 2025397.8
02 Jan 2025395.9
01 Jan 2025403.15

SWOT Analysis Of Hikal Ltd

Strength

3

che

Weakness

2

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Hikal Ltd

Asset Value vs Market Value of Hikal Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Hikal Ltd4512
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Hikal Ltd Explained

``

4512

Market cap

73

Earnings

61.4X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Hikal Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Hikal Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Hikal Ltd

No data available

* All values are in %

About Hikal Ltd

  • Hikal Limited, incorporated on July 08th, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specialty chemicals.
  • The Company is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities.
  • Presently, it is operating in the crop protection and pharmaceuticals space. The Company has 5 manufacturing facilities across three states in India.
  • It supply products to customers across the globe in the US, Japan, Europe, Canada, South East Asia, LATAM, India and RoW. Apart from this, it specialize in manufacturing APIs and intermediates in pharmaceutical division.
  • Within pharmaceutical division, it offer human health and animal health products.

Hikal Ltd News Hub

Hikal consolidated net profit declines 26.09% in the June 2024 quarter

Net profit of Hikal declined 26.09% to Rs 5.10 crore in the quarter ended June 2024 as against Rs 6.

Read more

2024-08-01 00:00:00

Hikal AGM scheduled

Hikal announced that the Annual General Meeting (AGM) of the company will be held on 17 September 20

Read more

2024-08-23 00:00:00

Hikal appoints Head - Information Technology

Hikal has appointed Pankaj Sharma has been appointed as a Senior Management Personnel of the Company

Read more

2024-12-26 00:00:00

Hikal to announce Quarterly Result

Hikal will hold a meeting of the Board of Directors of the Company on 12 November 2024 Powered by Ca

Read more

2024-11-06 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Hikal Ltd

What is the current PE Ratio of Hikal Ltd?

The Current PE Ratio of Hikal Ltd is 61.4 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Hikal Ltd last year?

The PE Ratio of Hikal Ltd was 44.32 last year, now the PE ratio is 61.4, showing a year-on-year growth of 38.5%.

What does the PE Ratio of Hikal Ltd indicate about its stock?

The PE Ratio of Hikal Ltd is 61.4. This ratio indicates that investors are willing to pay 61.4 times the earnings per share for each share of Hikal Ltd.

What is the PE Ratio Growth of Hikal Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Hikal Ltd grew by 38.5% whereas, the EPS ratio grew by 261.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions